Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.34 |
| ▸ | RELA | Q04206 | 1/20 | 0.34 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7425487 | 0.73 | — | — | |
| SCHEMBL3423875 | 0.72 | ALDH1A1 (0.34) | ALDH1A1MAPK1SMN1; SMN2NPC1NFKB1 | |
| SCHEMBL29780994 | 0.72 | — | — | |
| SCHEMBL29871014 | 0.71 | ALDH1A1 (0.44) | ALDH1A1MAPK1SMN1; SMN2NPC1NFKB1 | |
| SCHEMBL6563901 | 0.71 | ALDH1A1 (0.38) | ALDH1A1MAPK1SMN1; SMN2NPC1NFKB1 | |
| SCHEMBL28443486 | 0.70 | KCNN4 (0.36) | ALDH1A1SMN1; SMN2NPC1RAB9AMEN1 | |
| SCHEMBL11364223 | 0.69 | ALDH1A1 (0.32) | ALDH1A1MAPK1 | |
| SCHEMBL31235510 | 0.68 | ALDH1A1 (0.38) | ALDH1A1MAPK1SMN1; SMN2NPC1NFKB1 | |
| SCHEMBL19856405 | 0.68 | ALDH1A1 (0.35) | ALDH1A1MAPK1SMN1; SMN2NPC1NFKB1 | |
| SCHEMBL31549865 | 0.68 | LPL (0.34) | ALDH1A1MAPK1SMN1; SMN2NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12145898-B2 | Compound, composition comprising same, and organic light emitting diode comprising same | LG CHEM, LTD. (KR) | 2024-11-19 | — | — | US | disclosed |
| WO-2020060271-A1 | COMPOUND, COMPOSITION COMPRISING SAME, AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | 주식회사 엘지화학 | 2020-03-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12145898-B2 | Compound, composition comprising same, and organic light emitting diode comprising same | CRY1, SEM1, NOTUM | ALDH1A1 9/4885MAPK1 1041/4885SMN1; SMN2 2565/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.